We are thrilled to announce that our branch, VETOS Brazil, is now officially operational and open in BRAZIL🇧🇷 Our Business and Technical Director, Luciano Sá , is available to assist you with any inquiries. Please feel free to contact him at the following details:...

We are delighted to announce that Anavrin for the second consecutive year, is featured in the ESG sustainability report issued by Hunland Group, prepared in accordance with GRI standards. This recognition underscores our commitment to sustainability and responsible...

We are pleased to announce that Anavrin's Carbon Footprint corresponding to the average daily dose consumed by a bovine is negligible. According to the simplified Life Cycle Assessment (LCA) conducted in collaboration with the carbon advisor Rete Clima, Anavrin's...

Effective July 2nd , 2025, Luciano Sá has assumed the position of Business and Technical Director for Brazil at VETOS EUROPE. In his new role, Luciano Sá will be responsible for the implementation of the key account strategy as well as managing the technical and...

We are pleased to share the positive findings from a comprehensive one-year trial conducted on 98 dairy buffalo in Caserta, southern Italy in collaboration with Università degli Studi di Napoli Federico II. This study investigated the effects of Anavrin on various...

We are excited to announce that Anavrin has commenced a new trial in collaboration with the Università degli Studi di Milano . This trial focuses on calves and aims to confirm the effectiveness of our product for use in young ruminants, specifically measuring its...

The European Union (EU) has officially approved a significant regulatory decision to ban the import of edible animal products derived from animals treated with antimicrobial compounds, including Monensin, for growth promotion after September 2026. This regulatory...

We are thrilled to share that our abstract titled "Evaluating the effects of a methane mitigating additive (Anavrin) on feed intake, milk production, and emissions in Holstein dairy cows," developed at Wageningen University & Research, has been accepted for...

We are thrilled to announce the remarkable outcomes of a one-of-a-kind trial in Europe, conducted over an extensive 210 days (7months) in collaboration with Università degli Studi di Milano. This extensive period allowed us to gain unparalleled insights into measuring...